Epizyme and HUTCHMED Announce Strategic Collaboration to Develop and Commercialize TAZVERIK (tazemetostat) in Greater China Read more
FDA approves Nexviazyme (avalglucosidase alfa-ngpt), an important new treatment option for late-onset Pompe disease Read more
Kite and Appia Bio Announce Collaboration to Research and Develop Allogeneic Cell Therapies for Cancer Read more
10 key reasons to join SMi’s 2nd Annual Next Generation Pharmaceutical Cleanroom Conference Read more
Amring Pharmaceuticals Inc. Announces the Approval and Launch of Generic Isoproterenol Hydrochloride Injection USP Read more
Akston Biosciences Doses First Subjects in Phase II Clinical Trial of Second-Generation Protein Subunit COVID-19 Vaccine Read more
Exclusive Interview with Alexander Stoll, Fresenius Kabi AB speaker at SMi’s Aseptic Processing Conference Read more
NRx Pharmaceuticals Partners with MannKind Corporation to Develop ZYESAMI (aviptadil) Inhaler for Respiratory Conditions Read more
BioNTech Completes Acquisition of Kite’s Neoantigen TCR Cell Therapy R&D Platform and Manufacturing Facility in Gaithersburg, Maryland Read more